Clinical study of budesonide combined with hydrocortisone in the treatment of infantile asthmatic bronchopneumonia
布地奈德联合氢化可的松治疗小儿喘息性支气管肺炎的临床研究

摘要

目的 探讨在小儿喘息性支气管肺炎治疗时采取布地奈德联合氢化可的松药物的效用价值。方法 研究中共选取符合此病症的患者118例进行对比实验，采取摇号方式分为对照与观察两个组别，各59例，前者采取布地奈德混悬液药，后者联合使用氢化可的松，对比两组患者治疗前后肺功能指标以及治疗有效率。结果 通过所得数据来看，观察组患者的治疗效果明显较好，患者的肺功能也得到有效改善。结论 将布地奈德联合氢化可的松用于小儿喘息性支气管炎治疗中有显著治疗效果。

Abstract

Objective: To explore the utility value of budesonide combined with hydrocortisone in the treatment of asthmatic bronchopneumonia in children.
Methods: In the study, a total of 118 patients with this disease were selected for comparative experiments. They were divided into control and observation groups by lottery, with 59 cases in each group. The former took budesonide suspension and the latter was combined with hydrocortisone. Song, compare the pulmonary function indexes before and after treatment and the effective rate of treatment between the two groups of patients.
Results: According to the data obtained, the treatment effect of the observation group was significantly better, and the lung function of the patients was also effectively improved.
Conclusion  : The combination of budesonide and hydrocortisone in the treatment of asthmatic bronchitis in children has a significant therapeutic effect.